2018-07-11T09:43:38-07:00 2017-08-31 990 2016-09-01 581698648 THE TASK FORCE FOR GLOBAL HEALTH INC TASK 4045921430 325 Swanton Way Decatur GA 300303001 William Nichols Chief Operating Officer 4045921430 2018-05-01 2016 2022-09-23 18:48:47Z David Ross 325 Swanton Way Decatur GA 30030 85921983 0 X www.taskforce.org X 1986 GA The mission of The Task Force for Global Health is to solve large-scale health problems affecting vulnerable populations around the world and to build sustainable systems that protect and promote health. 9 8 131 7 0 0 49921070 85304040 0 0 8370 89763 0 317413 49929440 85711216 3234124 5771652 0 0 13659944 15915752 0 0 147507 32191693 40655354 49085761 62342758 843679 23368458 49765630 80897001 6171762 13934675 43593868 66962326 The mission of The Task Force for Global Health is to solve large-scale health problems affecting vulnerable populations around the world and to build sustainable systems that protect and promote health. 0 0 28388132 328910 28014198 The Health Systems Strengthening Area includes PHII (Public Health Informatics Institute); TEPHINET (Training Programs in Epidemiology and Public Health); and African Health Workforce Project. PHII provided direct services to the U.S. public health system through a cooperative agreement with the CDC and funding from the de Beaumont and Robert Wood Johnson foundations. This funding supported state and local health departments in developing immunization information systems; CDC in developing an immunization information strategy; PHII and its partners in providing technical assistance and online tools to state and local health departments in linking to private healthcare electronic records systems for the purpose of electronic case reporting; and PHII in providing training to public health professionals in essential informatics competencies. The funding also supported the continuing development and use of a workforce deployment tool that assists African countries in allocating health workers to high-need areas in order to strengthen HIV treatment and prevention. Additionally, PHII is a partner on a collaborative Gates Foundation-funded project that is collecting data to reduce childhood mortality across the globe; this project launched six new surveillance sites in Asia and Africa this year. TEPHINET continued its mission of supporting Field Epidemiology Training Programs (FETPs) throughout the world. TEPHINET was awarded a cooperative agreement from the CDC to continue its support of FETPs in countries such as Pakistan, Bangladesh, Egypt, Tanzania, and Morocco, to name a few. Support was provided to FETP residents who were being trained to conduct infectious and chronic disease surveillance and to implement control and prevention efforts. FETP residents received training in general epidemiology topics such as outbreak investigation, research and methodology, and biostatics, and training was also tailored to disease specific issues in the residents' regions. In addition, TEPHINET provided robust networking and continuing education opportunities for FETP residents and graduates by hosting a global scientific conference in September 2015 that was attended by over 500 public health officials from 60 countries. Workshops and abstract presentations provided the most up to date information about trends and research in epidemiology and global public health. There were two additional CDC cooperative agreements that TEPHINET managed over the last year. The Latin America cooperative agreement implemented initiatives throughout the region to increase awareness and response to non-communicable diseases, such as heart disease and cancer. The final cooperative agreement implemented by TEPHINET is the National Stop Transmission of Polio (N-STOP) program, which provided technical assistance to immunization campaigns throughout Pakistan. African Health Workforce Project: Countries worldwide are challenged by health worker shortages and an imbalance of skilled health professionals. Often there is an abundance of skilled workers in some regions while other communities are lacking. Regulatory agencies, charged with ensuring the quality of the education and skills of the healthcare professionals, are often underfunded and lack basic resources such as information systems, frameworks for continuous professional education and IT infrastructure. Healthcare managers need adequate information about the supply and demand for healthcare workers to manage their workforce more efficiently, plan for scale up of the workforce, ensure proper regulation of professionals, and to develop effective human resource policies. However, many countries lack computerized data systems that can provide these critical data. The African Health Workforce Project is designed to address these issues by assisting health professional regulatory agencies in development of human resource information systems, improvement of IT infrastructure, and collaborative forums to assist them in strengthening regulatory functions to improve professional standards in the east, central, and southern regions of Africa. 20654623 5399770 31741635 The Neglected Tropical Disease Area includes: CWW (Children Without Worms); ITI (The International Trachoma Initiative); NTD-SC (the Neglected Tropical Disease-Support Center); and MDP (The Mectizan Donation Program). With funding from Johnson & Johnson (J&J) and GlaxoSmithKline, Children Without Worms (CWW) is developing and implementing a shared strategic vision among key soil-transmitted helminthiasis (STH) partners. In 2017, CWW successfully designed and implemented model STH programming. As the STH Coalition secretariat, CWW leveraged the strengths of a diverse set of STH partners to strengthen preventive chemotherapy coverage among partners. Years of CWW efforts to expand focus of national STH programs beyond children, namely to women of reproductive age (WRA), bore fruit in 2017. In 2017, CWW demonstrated the ability to provide transformative value, through the ministry of health, to the Bangladesh STH program. Using a CWW-developed methodology, CWW and the national program conducted six district-level population-based program monitoring surveys measuring: disease levels, PC coverage, and water and sanitation coverage. In Bangladesh, the increased attention toward program monitoring is an important part of a new, first-ever, national STH strategic plan which is now undergoing official review. The Plan intends to operationalize programmatically the goal of eliminating STH as a public health problem. As secretariat for the STH Advisory Committee, the recognized technical body for STH-related issues, CWW demonstrated the value of the Committee again at the November 2017 meeting where participants addressed diagnostics, program monitoring, and goals-linked standard metrics to measure progress. The resulting recommendations will shape an emerging WHO strategy for STH control post-2020. Funded principally by the Bill & Melinda Gates Foundation and the U.S. Agency for International Development, the NTD-SC aims to optimize Operational Research (OR) to eliminate neglected tropical diseases which threaten the lives and well-being of more than one billion of people in some of the world's poorest communities. As of 2016, the NTD-SC manages a portfolio of more than 115 OR projects spanning 53 countries and targeting all five neglected tropical diseases amenable to preventive chemotherapy: lymphatic filariasis, onchocerciasis, STH, schistosomiasis and trachoma. Some of these OR study products have resulted into program recommendations which the World Health Organization (WHO) has endorsed and adopted into WHO policy. In addition, the NTD-SC serves as the Secretariat for the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) yearly meeting. This meeting brings together a growing group of researchers and country program implementers working to foster important collaborations to address the challenges faced by NTD programs which prevent the shared goal of eliminating these infections. The 2-day event featured Jimmy Carter as keynote speaker and convened nearly four hundred individuals from more than 30 countries, translating ideas into future OR projects for 2017. ITI has established a unique competitive advantage within the global trachoma community based on its singular focus on trachoma, its credibility as a neutral convener and trusted ally, its flexibility and ability to lead initiatives in support of scale-up, and its role as the sole steward of Pfizer, Inc.'s Zithromax(R) drug donation. ITI fulfills three value-adding roles that contribute to the implementation of the WHO-endorsed SAFE strategy (Surgery, Antibiotic treatment, Facial cleanliness, Environmental improvement , namely: 1) stewardship of the Zithromax(R) drug donation; 2) program delivery strengthening, through operational research, knowledge sharing, capacity building and technical backstopping; and 3) partnership development, through support to the International Coalition for Trachoma Control (ICTC), spearheading WASH/NTD engagement, and mobilizing resources for trachoma. In 2017, ITI organized just-in-time shipments of over 84 million doses of Zithromax(R) to 26 countries, bringing the cumulative total of doses donated since its inception in 1998 to 717 million doses. Also in 2017, ITI launched the Zithromax(R) Shipment Tracker, a web-based open-access system to increase the transparency and visibility of the Zithromax(R) supply chain in support of effective planning by Ministries of Health and partners for their distribution campaigns. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision making on where antibiotic treatments are needed and where they can be stopped. ITI's commitment to strong stewardship of the antibiotic donation from Pfizer, coupled with its solid data management and transparent communications, have contributed to remarkable achievements by the global trachoma community in reducing the population at risk of blindness from this preventable disease from an estimated 1.2 billion people in 2000 to 182 million in 2017. With just three years left until the World Health Organization's global trachoma elimination goal, ITI will continue to enhance its support, improve its effectiveness, and increase its efficiencies to maximize impact. MDP- In 2017, 210.4 million treatments were approved for mass drug administration (MDA) for river blindness elimination in 24 African countries and 2 countries in Latin America. For Lymphatic filariasis (LF), 254.5 million Mectizan treatments were approved for co-administration with albendazole in 23 countries. In April 2017, Togo became the first country in Africa to eliminate lymphatic filariasis. This was a very exciting development as Togo demonstrated that the ambitious goal to eliminate LF can be achieved through dedication, determination, and commitment. From 2016 to 2017, 65 additional implementation units (IU) stopped treatment for LF. The number of people who no longer need Mectizan and albendazole for LF elimination increased from 22.4 million in 2016 to 118 million in 2017 -- a strong indicator that countries are getting closer to eliminating the disease. In some implementation units (IUs) Mectizan for river blindness elimination is still needed as transmission has not been interrupted. More than 23 million people continue to receive Mectizan for river blindness in areas where LF transmission has been eliminated. In 2017, Nigeria stopped treatment with Mectizan for river blindness elimination in 13 local government areas (LGAs) in Nasarawa and Plateau states resulting in an astounding 2.1 million people who no longer need treatment as transmission has been interrupted in the region. This is a remarkable achievement by the people of Plateau and Nasarawa, Nigeria's Federal Ministry of Health and NGO partner The Carter Center. Achieving elimination at this scale is proof of concept that river blindness will be a distant memory in the years to come. Ethiopia also made great strides in 2017 by stopping treatment for river blindness in 6 districts in the Metema focus where 838,916 people no longer need Mectizan. Sudan was also able to stop treatment in the Galabat focus, which borders the Metema focus in Ethiopia. In Galabat, 254,987 people no longer need Mectizan for river blindness. 6568077 42971 7725615 In fiscal 2017, The Center for Vaccine Equity made substantial progress in existing programs. Polio program staff supported the Global Polio Eradication Initiative in assisting 16 priority countries in transitioning financial and technical resources from polio to other health system priorities; provided technical assistance to a 6 month multi-agency Polio Outbreak Response Assessment (OBRA) in Nigeria; published a compendium of lessons from the global polio eradication effort in a supplement to the Journal of Infectious Diseases; hosted the US National Polio Containment Certification Committee; published in Frontiers in Immunology the results of a global survey on the incidence of poliovirus excretion in immunocompromised persons; and advanced development of a polio antiviral combination drug therapy. The influenza program supported 8 countries with building their national influenza vaccination programs through funding and technical assistance to expand surveillance, training, and communications, and with direct donation of >500,000 doses of vaccine among four countries. The influenza program has expanded its role in global influenza response with the establishment of a consortium of funders supporting development of a universal influenza vaccine. The Center has been designated by CDC as the co-conference organizer for the 2018 National Immunization Conference and the International Conference on Emerging Infectious Diseases. 0 0 0 55610832 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 1 0 1 1 1 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 122 0 0 131 1 0 1 CO ET GT 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 GA X Daniel N Martins 4046875620 325 Swanton Way Decatur GA 300303001 Teri Plummer McClure Board Chair 1 0 X 0 0 0 James W Curran Board Member 1 0 X 0 0 0 Paula Lawton Bevington Board Member 1 0 X 0 0 0 Mary Ann Peters Board Member 1 0 X 0 0 0 Charles H McTier Board Member 1 0 X 0 0 0 David A Ross President and CEO 39 1 X X 326328 0 46104 William P Nichols Chief Operating Officer 39 1 X 227966 0 21050 Heather Brooks Director of Organizational Effectiveness 39 1 X 167248 0 32419 Mark McKinlay Program Director 39 1 X 224275 0 43975 Daniel Martins Chief Financial Officer 40 0 X 139857 0 48298 Eric Ottesen Program Director 40 0 X 243307 0 19510 Martha Rogers Program Director 40 0 X 228037 0 25079 David G Addis Program Director 40 0 X 215475 0 42532 Dionisio Jose Herrera Guibert Program Director 40 0 X 187668 0 50297 Paul Emerson Program Director 40 0 X 201519 0 32219 Yao Sodahlon Program Director 40 0 X 162370 0 47548 Ellen Wild Director of Business Strategy 40 0 X 153841 0 14284 Vivian Singleton Program Director 40 0 X 166983 0 35662 Timothy Morris Chief Information Officer - PHII/CHAMPS 40 0 X 186710 0 49533 Maria Rebollo Polo Associate Director 40 0 X 162400 0 42630 Kisito Ogoussan Associate Director 40 0 X 120737 0 37134 James Nguyen Chief Information Officer 40 0 X 120208 0 48111 Debra Bara Director of Partnerships 40 0 X 119244 0 34051 Jane Fugate Thorpe Board Chairman 1 0 X 0 0 0 George Alleyne Board Member 1 0 X 0 0 0 Carol C Walters Board Treasurer 1 0 X 0 0 0 Mark Rosenberg President and CEO 39 1 X 336574 0 33161 Alan R Hinman Sr. Public Health Scientist 40 0 X 172871 0 16439 Adrian Hopkins Program Director 40 0 X 203527 0 20631 4067145 0 740667 37 1 1 0 First American Title Insurance Company Six Concourse Pkwy Suite 2000 Atlanta GA 30328 Title Insurance Company 5318232 Care and Health Program PO Box 2338 Yaounde CM Logistics services 533968 Deloitte Consulting LLP 4022 Sells Drive Hermitage TN 37076 Consulting services 624295 Seqirus Pty Ltd 63 Poplar Road Parkville Victoria AS 3052 Manufactures and in-licenses, markets and distributes vaccines 594464 ViroDefense Inc 5425 Wisconsin Avenue Suite 600 Chevy Chase MD 20815 Antiviral research and development consulting 4173499 61 0 0 10201180 0 27629966 47472894 0 85304040 0 89763 89763 0 0 0 0 0 0 0 0 0 0 528180 0 210767 0 317413 0 317413 317413 0 0 0 0 10201180 0 85711216 407176 0 0 0 0 0 0 5771652 5771652 4532528 1855852 2632074 44602 0 0 0 0 8773864 7560213 1180427 33224 722960 622956 97266 2738 1308032 1071724 230252 6056 578368 498365 77813 2190 16945303 16595009 298905 51389 40485 7026 33459 0 58175 17825 40350 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 87213 75491 5861 5861 2187564 2133339 54225 0 931047 649094 281953 0 0 0 0 0 534922 254503 280419 0 3563498 3401465 162033 0 0 0 0 0 1829230 1616829 212372 29 274028 0 274028 0 0 0 0 0 368316 0 368316 0 122054 47113 74941 0 Dues and Subscriptions 71948 18457 52095 1396 Bank Charges 73746 68001 5723 22 Indirect Cost Expense 7305065 7305065 0 0 Other Direct Program Expense 6178882 5986281 192601 0 83878 54572 29306 0 62342758 55610832 6584419 147507 0 0 39779402 55018822 4384849 6153650 0 0 0 0 0 0 0 0 0 0 527370 216765 22548476 3040712 5074009 19507764 0 0 0 0 0 0 0 0 0 0 49765630 80897001 1756074 2072587 0 0 0 0 3000000 6825000 0 0 0 0 0 0 0 0 1415688 5037088 6171762 13934675 X 14074159 25472002 29519709 41490324 0 0 43593868 66962326 49765630 80897001 23368458 0 0 0 0 0 X 0 1 X 1 1 1 X 30364206 29925159 35776510 42374053 68115208 206555136 0 0 0 0 0 0 0 0 0 0 0 0 30364206 29925159 35776510 42374053 68115208 206555136 42011641 164543495 3763 3966 4472 8370 89763 110334 0 0 0 0 0 0 0 0 0 0 0 0 206665470 0 0.79618 0.8233 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2135100 0 2135100 19224027 0 1914475 17309552 0 0 0 0 1068684 0 1005574 63110 120665 0 120663 2 19507764 0 Payroll Liabilities 1298655 Accrued Absences 275837 Other Acruals 3462596 5037088 85711216 0 0 0 0 0 85711216 0 0 0 85711216 62342758 0 0 0 0 0 62342758 0 0 0 62342758 1 Central America and the Caribbean 0 0 Program Services Public health and research grants to (1)address needs in certain areas of neglected tropical diseases, (2) strengthen health systems and (3)help in eliminating vaccine-preventable diseases 280155 East Asia and the Pacific 0 0 Program Services Public health and research grants to (1)address needs in certain areas of neglected tropical diseases, (2) strengthen health systems and (3)help in eliminating vaccine-preventable diseases 628321 South Asia 0 0 Program Services Public health and research grants to address the needs in certain areas of neglected tropical diseases 1040259 Sub-Saharan Africa 1 14 Program Services Public health and research grants to address needs in certain areas of neglected tropical diseases, and strengthen health systems. 3476296 Middle East and North Africa 0 0 Program Services Public health and research grants to address needs in certain areas of neglected tropical diseases. 53250 South America 0 0 Program Services Public health and research grants to address the needs in certain areas of neglected tropical diseases 438 Europe (including Iceland and Greenland) 0 0 Program Services 111 292932 1 14 5771651 Central America and the Caribbean Public health and research grants to (1)address needs in certain areas of neglected tropical diseases, (2) strengthen health systems and (3)help in eliminating vaccine-preventable diseases 280155 Wire transfer 0 East Asia and the Pacific Public health and research grants to (1)address needs in certain areas of neglected tropical diseases, (2) help in eliminating vaccine-preventable diseases 628321 Wire transfer 0 South Asia Public health and research grants to address needs in certain areas of neglected tropical diseases, 1040259 Wire transfer 0 Sub-Saharan Africa Public health and research grants to address needs in certain areas of neglected tropical diseases, 3476296 Wire transfer 0 Middle East and North Africa Public health grants to address needs in certain areas of neglected tropical diseases. 53250 Wire transfer 0 0 12 0 0 0 0 0 0 Schedule F, Part I, Line 2 A contract is executed with all the required deliverables and budget. Based on work performance, an agreed percentage is paid to the recipient after receiving an invoice and a narrative report. Occasionally, there are visits to the countries for feedback and to assess the impact of the project. Budget over-runs have to be explained before a contract amendment, if necessary, is made. Capital Campaign 10201180 0 10201180 0 0 0 0 0 147507 0 0 10201180 0 10201180 0 0 0 0 0 147507 147507 10053673 X X 0 0 0 0 0 0 0 0 0 Teri Plummer McClure Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jane Fugate Thorpe Board Chairman 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Paula Lawton Bevington Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 James W Curran Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Charles H McTier Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 George Alleyne Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Mary Ann Peters Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Carol C Walters Board Treasurer 0 0 0 0 0 0 0 0 0 0 0 0 0 0 David A Ross President and CEO 326328 0 0 0 0 0 22400 0 23704 0 372432 0 0 0 Mark Rosenberg President and CEO 293796 0 0 0 42778 0 23850 0 9311 0 369735 0 0 0 William P Nichols Chief Operating Officer 227966 0 0 0 0 0 20510 0 540 0 249016 0 0 0 Heather Brooks Director of Organizational Effectiveness 152452 0 14796 0 0 0 10551 0 21868 0 199667 0 0 0 Ellen Wild Director of Compliance 148841 0 5000 0 0 0 13433 0 850 0 168124 0 0 0 Mark McKinlay Program Director 224275 0 0 0 0 0 20574 0 23401 0 268250 0 0 0 Daniel Martins Chief Financial Officer 124325 0 0 0 15532 0 11675 0 36623 0 188155 0 0 0 Eric Ottesen Program Director 243307 0 0 0 0 0 18252 0 1258 0 262817 0 0 0 Martha Rogers Program Director 228037 0 0 0 0 0 20010 0 5069 0 253116 0 0 0 Alan R Hinman Sr. Public Health Scientist 172871 0 0 0 0 0 15619 0 820 0 189310 0 0 0 David G Addis Program Director 215475 0 0 0 0 0 19170 0 23362 0 258007 0 0 0 Dionisio Jose Herrera Guibert Program Director 187668 0 0 0 0 0 17643 0 32654 0 237965 0 0 0 Adrian Hopkins Program Director 203527 0 0 0 0 0 13491 0 7140 0 224158 0 0 0 Paul Emerson Program Director 201519 0 0 0 0 0 18485 0 13734 0 233738 0 0 0 Yao Sodahlon Associate Director 162370 0 0 0 0 0 15107 0 32441 0 209918 0 0 0 Vivian Singleton Program Director 161253 0 0 0 5730 0 13809 0 21853 0 202645 0 0 0 Timothy Morris Chief Information Officer - PHII/CHAMPS 186710 0 0 0 0 0 16886 0 32647 0 236243 0 0 0 James Nguyen Chief Information Officer 120208 0 0 0 0 0 11487 0 36624 0 168319 0 0 0 Maria Rebollo Polo Associate Director 162400 0 0 0 0 0 12164 0 30466 0 205030 0 0 0 Kisito Ogoussan Associate Director 120737 0 0 0 0 0 11451 0 25684 0 157872 0 0 Debra Bara Director of Partnerships 119244 0 0 0 0 0 11103 0 22948 0 153295 0 0 0 A Development Authority of DeKalb County 581500666 000000000 2016-12-15 7000000 Finance the purchase of a new building 0 0 0 A 175000 0 7000000 0 124951 0 0 0 0 7000000 0 0 2018 0 0 1 1 A 0 0 0 0 0 0 0 1 0 0 A 0 0 0 0 1 0 0 0 0 A 0 Form 990, Part VI, Section B, Line 11b Once the Return is prepared by the CFO, it is made available to all board members for comments,clarifications and corrections. After the board's review, the Return is finalized and filed with the IRS. Form 990, Part VI, Section B, Line 12c Board members, officers, and all employees are required to annually sign a declaration that they have read, and have complied with, the Conflict of Interest Policy. Any suspected or reported violations of the policy are to be referred to the Chief Operating Officer who would follow-up and investigate the matter. Form 990, Part VI, Section B, Line 15 The Task Force for Global Health, Inc. is an affiliate of Emory University and as such, all its employees are in fact Emory employees. For both the President and Chief Operating Officer, Emory includes these positions in its annual market review of compensated professionals in these categories. In addition, performance is measured against SMART goals. Furthermore, the board reviews performance including a 360 feedback loop finalizing the President's performance. Form 990, Part VI, Section C, Line 19 Three years of audited financial statements and 990 Tax Returns are posted on the organization's website together with the Conflict of Interest policy and governing documents - Bylaws. Global Health Solutions Inc 325 Swanton Way Decatur GA 30030 203674498 Provide programmatic support to the Task Force GA 501(c)(3) 509(a)(3) Type 1 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 Global Health Solutions Inc n 50000 Fair market value of $25/sqft for 150sqft($45,000/year) and an estimated $5,000 for equipment use Global Health Solutions Inc o 80000 Different employees at different stages of the process help to support Global Health Solutions(GHS). I estimate that if a full time employee hired purposefully for GHS, salary and benefits may be about $80,000.00